Director, Peer-to-Peer Marketing

About CG Oncology, Inc.

Are you ready to make a difference in the world and become part of our patient-centered team that is focused on Attacking Bladder Cancer for a Better Tomorrow? At CG Oncology, we believe that by having exceptionally talented individuals on our team who share our passion and enjoy working together, we can truly achieve our Vision and Mission to benefit patients around the world.

Every day we are making significant advancements across our multiple pipelines and are growing rapidly to meet the needs of our patients who cannot afford to wait to benefit from our novel immunotherapies. Please review this job posting and our Values and if they resonate with you and are what you expect from your organization and team, then we would like to hear from you.

About the role

CG Oncology is seeking a Director of Peer-to-Peer marketing to design and lead our thought leader initiatives across the pre-launch, launch and post-launch lifecycle. 

The Director, Peer-to-Peer Marketing will lead the development and execution of the peer-to-peer (P2P) strategy for cretostimogene (“creto”) as CG Oncology prepares for its first commercial launch in non-muscle invasive bladder cancer (NMIBC).

This individual will build a comprehensive physician-to-physician engagement strategy designed to educate urologists and other appropriate healthcare professionals on the evolving NMIBC treatment landscape, appropriate patient identification, and the potential role of cretostimogene.

The Director, Peer-to-Peer Marketing will be responsible for creating the strategy, infrastructure, content and operating model required to deliver high-quality peer education across national, regional, local and digital channels. This includes speaker strategy, speaker identification and development, speaker programs, advisory engagement, peer-to-peer content, field integration and measurement.

The role will initially focus on high-risk BCG-unresponsive NMIBC while building the capabilities and insights required to support potential future indications, including intermediate-risk NMIBC.

They will work closely with HCP Marketing, Sales, Medical Affairs, Commercial Operations, Insights & Analytics, Market Access, Regulatory, Legal and Compliance.

Essential Functions

Thought Leader Strategy

• Develop and own the integrated peer-to-peer marketing strategy for cretostimogene.
• Define the strategic role of P2P education within the overall brand and launch strategy.
• Identify the physician behaviors, knowledge gaps and adoption barriers that can most effectively be addressed through peer education.
• Develop distinct P2P strategies for pre-launch, launch and post-launch phases.
• Determine the appropriate balance of national, regional, local, in-person and virtual peer engagement.
• Ensure P2P strategy is tightly integrated with HCP Marketing, Sales, Medical Affairs and the broader customer engagement strategy.
• Develop an approach that can evolve as cretostimogene potentially expands into additional NMIBC patient populations.

Speaker Strategy Development

• Develop the overall commercial speaker strategy and speaker bureau operating model.
• Identify the types, number and geographic distribution of speakers required to support launch.
• Partner with appropriate internal stakeholders to identify qualified potential speakers.

• Develop speaker selection criteria based on clinical expertise, credibility, communication capabilities, customer relevance and geographic needs.
• Lead speaker onboarding, training and certification in partnership with appropriate cross-functional stakeholders.
• Build a diverse speaker faculty capable of engaging academic, community and other relevant urology audiences.

Congress Management

• Lead development and execution of the integrated commercial congress strategy for cretostimogene, ensuring congress activities support overall brand objectives and launch priorities.
• Develop the annual congress plan, identifying priority national and regional meetings based on customer concentration, strategic importance, launch timing and business objectives.
• Define the commercial objectives, target audiences, key messages and desired customer actions for each priority congress.
• Lead cross-functional commercial congress planning in partnership with HCP Marketing, Sales, Medical Affairs, Market Access, Corporate Communications and other relevant functions.
• Develop integrated congress engagement plans spanning promotional booth presence, peer-to-peer programs, customer engagements, field activities and other commercial channels.
• Partner with HCP Marketing to develop the promotional booth strategy, customer experience, messaging, content and supporting materials.
• Develop congress-specific peer-to-peer strategies, including speaker programs, expert panels and other compliant physician-to-physician engagements.
• Coordinate with Medical Affairs to ensure commercial activities appropriately complement scientific communications, data presentations and independent medical engagement while maintaining appropriate functional boundaries.
• Ensure all commercial congress activities are conducted in accordance with applicable Regulatory, Legal and Compliance requirements.

High Risk to Intermediate Risk Strategy

• Develop the overall commercial speaker strategy and speaker bureau operating model.
• Identify the types, number and geographic distribution of speakers required to support launch.
• Partner with appropriate internal stakeholders to identify qualified potential speakers.
• Develop speaker selection criteria based on clinical expertise, credibility, communication capabilities, customer relevance and geographic needs.
• Lead speaker onboarding, training and certification in partnership with appropriate cross-functional stakeholders.
• Build a diverse speaker faculty capable of engaging academic, community and other relevant urology audiences.
• Establish processes for ongoing speaker evaluation, development and optimization.
• Ensure appropriate succession and expansion of the speaker faculty as the brand and indications evolve.

Cross-Functional Launch Leadership

• Serve as the primary Marketing lead for commercial peer-to-peer strategy.
• Partner closely with HCP Marketing to ensure P2P activities reinforce overall brand strategy.
• Collaborate with Sales leadership on customer targeting, program planning and field execution.
• Partner with Medical Affairs to maintain appropriate coordination between commercial and scientific engagement.

Qualifications

• Bachelor’s degree in marketing, business administration or a related field or equivalent years of experience required. MBA or other graduate degree preferred.\
• Ten (10+) years marketing experience.
• Significant experience in pharmaceutical marketing, with direct experience leading peer-to-peer or HCP marketing programs.
• Oncology experience strongly preferred; urology, bladder cancer or physician-administered oncology experience highly desirable.
• Demonstrated experience preparing for and/or executing a pharmaceutical product launch.
• Experience developing and managing commercial speaker bureaus and peer-to-peer programs.
• Strong understanding of HCP segmentation, targeting and customer engagement.
• Demonstrated ability to operate effectively within Regulatory, Legal and Compliance requirements.
• Up to 20-25% travel required.

Work Authorization for US Applicants: Applicants must be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment visa at this time.

Please note that CG Oncology does not accept unsolicited information and/or resumes from search firms or agencies for our job postings. Any resumes or client information submitted to our careers page or any employee of CG Oncology by any search firm or agency without an applicable contract in place will become the property of CG Oncology and no fee(s) will be paid.

Total Rewards

CG Oncology offers very competitive and comprehensive Total Rewards, helping to support and reward our global team of high-performing employees focused on developing bladder-saving therapeutics for patients afflicted with bladder cancer.

HIGHLY COMPETITIVE SALARIES

ANNUAL PERFORMANCE/MERIT REVIEWS

ANNUAL PERFORMANCE BONUSES

EQUITYSPECIAL RECOGNITION

Well-Being Benefits

In addition to our Total Rewards, CG Oncology offers a variety of Well-Being Benefits to meet the majority of the needs of our unique and growing workforce. These benefits are designed to support our team to achieve a healthy balance between work and their personal lives to remain refreshed, engaged, and creating an environment where each person can find a deeper meaning and purpose in their work.

Well-Being Benefits eligibility begins the 1st of the month after hire. While a majority of these benefits are for our US-based workforce, we continue to assess comparable levels of benefits for our international team members that are aligned with country-specific regulations and their national programs offered.

FULLY REMOTE WORK ENVIRONMENT

REST AND RECHARGE BENEFITS - Unlimited Flexible Time Off

HOLIDAYS - In 2026 we will observe 14 holidays

RETIREMENT - 401K with 100% company Safe Harbor match up to 4% of base salary

HEALTH (MEDICAL, DENTAL, VISION) - PPO & HDHP - Cigna/Principal

HEALTH SPENDING ACCOUNTS - HSA (with Annual Company Contribution), FSA, FSA-DC

ILLNESS & DISABILITY PROTECTION - Company Paid LTD Coverage + Voluntary Plans

LIFE INSURANCE - Company Paid 2 x base salary + Voluntary Plans

ADDITIONAL EXCLUSIVE BENEFITS - Voluntary Legal, Pet, Plus More

CG Oncology is an Equal Opportunity Employer:

All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status. At CG Oncology, we are building a community of intelligent and passionate team members that share our Vision, Mission and Values, and while the biotechnology space can feel limited in BIPOC, non-binary and even female representation, we endeavor to make hiring decisions that will continue to grow and support our team in the direction of maintaining cultural diversity and sustainability.